EP1908480A4 - INTERFERON- ALPHA REGULATOR

4 sheets

Every citation, both ways

Citations
Reference	Relation	Cited during
BONJARDIM ET AL: "Interferons (IFNs) are key cytokines in both innate and adaptive antiviral immune responses-and viruses counteract IFN action", MICROBES AND INFECTION, ELSEVIER, PARIS, FR, vol. 7, no. 3, 1 March 2005 (2005-03-01), pages 569 - 578, XP025368193, ISSN: 1286-4579, [retrieved on 20050301]	Non-patent	Search report
OHATA K ET AL: "Interferon alpha inhibits the nuclear factor kappa B activation triggered by X gene product of hepatitis B virus in human hepatoma cells", FEBS LETTERS, ELSEVIER, AMSTERDAM, NL, vol. 553, no. 3, 23 October 2003 (2003-10-23), pages 304 - 308, XP004468238, ISSN: 0014-5793	Non-patent	Search report
KIDA Y ET AL: "Interleukin-1 stimulates cytokines, prostaglandin E2 and matrix metalloproteinase-1 production via activation of MAPK/AP-1 and NF-kappaB in human gingival fibroblasts", CYTOKINE, ACADEMIC PRESS LTD, PHILADELPHIA, PA, US, vol. 29, no. 4, 21 February 2005 (2005-02-21), pages 159 - 168, XP004709247, ISSN: 1043-4666	Non-patent	Search report
SHARMA SONIA ET AL: "Triggering the interferon antiviral response through an IKK-related pathway", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, WASHINGTON, DC; US, vol. 300, no. 5622, 16 May 2003 (2003-05-16), pages 1148 - 1151, XP002459128, ISSN: 0036-8075, DOI: 10.1126/SCIENCE.1081315	Non-patent	Examiner
See also references of WO 2006129784A1	Non-patent	Examiner

5 members in 4 offices; this record represents the family

This recordMember, by publication datePriority claim

Priority claims
Document	Office	Kind	Date
2005163647	Japan	–	2005-06-03
2005163647	Japan	A	2005-06-03
2006311072	Japan	W	2006-06-02

Family members, oldest first
Document	Office	Kind
WO2006129784A1	World Intellectual Property Organization (WIPO)	A1	2006-12-07
EP1908480A1	European Patent Office (EPO)	A1	2008-04-09
JPWO2006129784A1	Japan	A1	2009-01-08
EP1908480A4This record	European Patent Office (EPO)	A4	2009-07-01
US2010068807A1	United States of America	A1	2010-03-18

9 legal events, as the office reported them to INPADOC

Point at a mark for the event

Legal events, newest first
	Event	Code
2013-01-09	Application deemed to be withdrawnWithdrawn18D	18D
2012-12-07	Information on the status of an ep patent application or granted ep patentGrantedSTATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWNSTAA	STAA
2010-03-10	First examination report despatched17Q	17Q
2009-07-01	Supplementary search report drawn up and despatchedA4	A4
2008-09-10	Request for extension of the european patent (deleted)DAX	DAX
2008-09-10	Designated contracting states (corrected)RBV	RBV
2008-04-09	Request for examination filed17P	17P
2008-04-09	Designated contracting statesAK	AK
2008-03-07	Public reference made under article 153(3) epc to a published international application that has entered the european phaseORIGINAL CODE: 0009012PUAI	PUAI

CPC, 42: C12N9/1205
C12N5/0639
C12N2501/24
A61P1/02
A61P1/04
A61P1/16
A61P11/00
A61P11/02
A61P11/06
A61P13/12
A61P17/00
A61P17/04
A61P17/06
A61P19/02
A61P19/06
A61P19/08
A61P21/00
A61P21/04
A61P25/00
A61P25/04
A61P27/02
A61P27/14
A61P29/00
A61P3/10
A61P31/04
A61P31/10
A61P31/12
A61P31/14
A61P31/16
A61P31/20
A61P31/22
A61P33/00
A61P35/00
A61P37/00
A61P37/02
A61P37/06
A61P37/08
A61P43/00
A61P5/14
A61P7/06
A61P7/10
A61P9/00
Filled: the office’s first classification
IPC, 21: A61K45 00
A61K31 7105
A61K48 00
A61P1 02
A61P1 04
A61P1 16
A61P3 10
A61P5 14
A61P7 06
A61P7 10
A61P9 00
A61P11 02
A61P11 06
A61P13 12
A61P17 00
A61P17 04
A61P17 06
A61P19 02
A61P19 06
A61P19 08
A61P21 00

Contracting states, 6: Switzerland
Germany
France
United Kingdom
Liechtenstein
Sweden

Interferon- alpha regulator